- Home
- PCRX vs HSTM Comparison
PCRX vs HSTM Comparison
Compare PCRX & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- HSTM
- Stock Information
- Founded
- PCRX 2006
- HSTM 1990
- Country
- PCRX United States
- HSTM United States
- Employees
- PCRX N/A
- HSTM N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- HSTM Computer Software: Programming Data Processing
- Sector
- PCRX Health Care
- HSTM Technology
- Exchange
- PCRX Nasdaq
- HSTM Nasdaq
- Market Cap
- PCRX 1.1B
- HSTM 960.2M
- IPO Year
- PCRX 2011
- HSTM 2000
- Fundamental
- Price
- PCRX $24.65
- HSTM $32.39
- Analyst Decision
- PCRX Buy
- HSTM Hold
- Analyst Count
- PCRX 9
- HSTM 2
- Target Price
- PCRX $30.11
- HSTM $30.00
- AVG Volume (30 Days)
- PCRX 1.2M
- HSTM 170.6K
- Earning Date
- PCRX 05-06-2025
- HSTM 04-29-2025
- Dividend Yield
- PCRX N/A
- HSTM 0.38%
- EPS Growth
- PCRX N/A
- HSTM 32.31
- EPS
- PCRX N/A
- HSTM 0.66
- Revenue
- PCRX $700,966,000.00
- HSTM $291,646,000.00
- Revenue This Year
- PCRX $9.48
- HSTM $6.51
- Revenue Next Year
- PCRX $11.31
- HSTM $5.69
- P/E Ratio
- PCRX N/A
- HSTM $49.19
- Revenue Growth
- PCRX 3.85
- HSTM 4.51
- 52 Week Low
- PCRX $11.16
- HSTM $23.92
- 52 Week High
- PCRX $31.67
- HSTM $34.24
- Technical
- Relative Strength Index (RSI)
- PCRX 51.22
- HSTM 53.84
- Support Level
- PCRX $24.10
- HSTM $30.38
- Resistance Level
- PCRX $25.35
- HSTM $32.82
- Average True Range (ATR)
- PCRX 1.49
- HSTM 0.93
- MACD
- PCRX 0.01
- HSTM 0.14
- Stochastic Oscillator
- PCRX 48.89
- HSTM 85.62
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.